Atlas Trials

A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease

Clinical trial NCT05413655 · RECRUITING

Trial details

NCT number
NCT05413655
Sponsor
Excelsior
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2022-08-08
Primary completion
2026-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.